Algert Global LLC Harmony Biosciences Holdings, Inc. Transaction History

Algert Global LLC

$4.25 Billion
Q4 2024

A detailed history of Algert Global LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Algert Global LLC holds 230,908 shares of HRMY stock, worth $7.66 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

230,908

Previous 90,941 153.91%

Holding current value

$7.66 Million

Previous $3.64 Million 118.42%

% of portfolio

0.19%

Previous 0.1%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$31.86 - $41.49 $4.46 Million - $5.81 Million	139,967 Added 153.91%	230,908 $7.95 Million
Q3 2024 Nov 12, 2024	SELL	$30.0 - $39.95 $350,100 - $466,216	-11,670 Reduced 11.37%	90,941 $3.64 Million
Q2 2024 Aug 14, 2024	SELL	$28.81 - $33.01 $720,250 - $825,250	-25,000 Reduced 19.59%	102,611 $3.1 Million
Q1 2024 May 14, 2024	SELL	$29.93 - $35.06 $973,622 - $1.14 Million	-32,530 Reduced 20.31%	127,611 $4.29 Million
Q4 2023 Feb 14, 2024	BUY	$19.2 - $33.78 $2.39 Million - $4.2 Million	124,456 Added 348.76%	160,141 $5.17 Million
Q3 2023 Nov 13, 2023	SELL	$31.89 - $39.03 $150,839 - $184,611	-4,730 Reduced 11.7%	35,685 $1.17 Million
Q2 2023 Aug 14, 2023	BUY	$30.5 - $37.4 $815,875 - $1 Million	26,750 Added 195.76%	40,415 $1.42 Million
Q1 2023 May 12, 2023	SELL	$30.8 - $53.92 $114,822 - $201,013	-3,728 Reduced 21.43%	13,665 $446,000
Q4 2022 Feb 13, 2023	BUY	$45.4 - $60.91 $108,506 - $145,574	2,390 Added 15.93%	17,393 $958,000
Q3 2022 Nov 15, 2022	SELL	$42.06 - $55.45 $11,860 - $15,636	-282 Reduced 1.84%	15,003 $664,000
Q2 2022 Aug 15, 2022	SELL	$33.54 - $52.15 $335,265 - $521,291	-9,996 Reduced 39.54%	15,285 $745,000
Q1 2022 May 16, 2022	BUY	$33.14 - $51.13 $837,812 - $1.29 Million	25,281 New	25,281 $1.23 Million

Others Institutions Holding HRMY

# of Institutions

257

Shares Held

46.7M

Call Options Held

119K

Put Options Held

50K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $1.96B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account

Algert Global LLC Harmony Biosciences Holdings, Inc. Transaction History